Drug intelligence / Profile preview

adenosine-5'-[beta, gamma-methylene]tetraphosphate

Development stage
Unknown
Modality
Small Molecules
01

Overview

Adenosine‑5′‑[beta,gamma‑methylene]tetraphosphate is a synthetic nucleotide analog consisting of an adenosine moiety linked to a tetraphosphate chain in which the bridging oxygen between the beta and gamma phosphates is replaced by a methylene group. This modification confers resistance to enzymatic hydrolysis by phosphatases and ATPases. The compound is primarily used as a biochemical tool in research settings to study nucleotide-binding proteins and enzymes that interact with ATP or related nucleotides. It can act as an inhibitor or substrate analog for various kinases and ATP-dependent enzymes due to its structural similarity to natural nucleotides but altered reactivity. There are no known therapeutic indications or clinical uses for this molecule; it is not approved as a pharmaceutical drug.[1][2][4]

Other names
Adenosine-5'-(Beta, Gamma-Methylene)Tetraphosphate(((((((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy)(hydroxy)phosphoryl)oxy)(hydroxy)phosphoryl)methyl)(hydroxy)phosphoryl)oxy)phosphonic acid{[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan‑2‑yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}methyl)(hydroxy)phosphoryl]oxy}phosphonic acid

Beyond the preview

Go deeper on adenosine-5'-[beta, gamma-methylene]tetraphosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on adenosine-5'-[beta, gamma-methylene]tetraphosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call